Epizyme, Inc.
Combination therapy for treating cancer

Last updated:

Abstract:

The present invention relates to compositions comprising inhibitors of human histone methyltransferase DOT1L and one or more therapeutic agents, particularly anticancer agents, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.

Status:
Grant
Type:

Utility

Filling date:

26 Aug 2016

Issue date:

7 Jan 2020